All Stories

  1. Diencephalic Syndrome: Clinical Features, Pathophysiology, and Long-Term Outcomes
  2. EZHIP in Pediatric Brain Tumors: From Epigenetic Mimicry to Therapeutic Vulnerabilities
  3. Recommended phase 2 dose for abemaciclib in combination with irinotecan and temozolomide in pediatric and young adult patients with relapsed/refractory solid tumors: Results from JPCS study (Part A)
  4. Solid Tumors in RASopathies: Insights from a Large Monocentric Cohort and Systematic Review of the Literature
  5. Trabectedin–irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series
  6. The influence of tumor location on the onset of endocrine deficits in pediatric brain tumor survivors
  7. Metronomic Chemotherapy: An Alternative Strategy in Cancer Treatment Based on Continuous Low-Dose Administration
  8. Sport Activities for Children and Adolescents: Part 2. Joint Position Statement of Paediatric Societies on Physical Activity and Sport Recommendations for Children With Specific Chronic Disease Conditions
  9. Museum-based therapeutic interventions in pediatric oncology: the ETRU4KIDS experience as a model for hospital wellness enhancement
  10. Platinum-Induced Ototoxicity in Pediatric Cancer Patients: A Comprehensive Approach to Monitoring Strategies, Management Interventions, and Future Directions
  11. Spatial Analysis Identifies CD147 as a Novel Marker of High-Grade Childhood Posterior Fossa Ependymoma
  12. Medulloblastoma in Adolescents and Young Adults (AYA): Bridging Pediatric Paradigms and Adult Oncology Practice
  13. Acquisition matters - how do scan parameters affect apparent diffusion coefficient estimates in pediatric rhabdomyosarcoma
  14. Platinum-induced ototoxicity and hearing impairment in children and adolescents
  15. Editorial: Adverse and toxic effects of childhood cancer treatments, volume II
  16. Elevating fungal care: bridging Brazil’s healthcare practices to global standards
  17. Burnout in Pediatric Oncology: Team Building and Clay Therapy as a Strategy to Improve Emotional Climate and Group Dynamics in a Nursing Staff
  18. Burnout in Pediatric Oncology: Team Building and Clay Therapy as a Strategy to Improve Emotional Climate and Group Dynamics
  19. Surgical Treatment of Solid Pseudopapillary Tumor in Pediatric Patients: Two Case Reports and a Brief Narrative Review
  20. Outcomes and Toxicity of Adult Medulloblastoma Treated with Pediatric Multimodal Protocols: A Single-Institution Experience
  21. Nutritional Challenges in Paediatric Oncology: Screening and Managing Malnutrition and Sarcopenia
  22. Malnutrition and sarcopenia in children with cancer
  23. Bioelectrical Impedance Analysis of Body Composition in Male Childhood Brain Tumor Survivors
  24. Characteristics and Management of Children with Appendiceal Neuroendocrine Neoplasms: A Single-Center Study
  25. Pathogenic G6PD variants: Different clinical pictures arise from different missense mutations in the same codon
  26. Central nervous system pediatric multi-disciplinary tumor board: a single center experience
  27. Longitudinal changes in retinal ganglion cell function in optic pathway glioma evaluated by photopic negative response
  28. The Role of the Cerebellum in Advanced Cognitive Processes in Children
  29. Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing
  30. Childhood Obesity and Metabolic Syndrome: A Review
  31. Prevalence of burnout and psycho-emotional disorders among non-health workers: a single tertiary care pediatric oncology center experience
  32. Psychological Experiences of Parents of Pediatric Cancer Patients during and after COVID-19 Pandemic
  33. Anthropometric parameters as a tool for the prediction of metabolic and cardiovascular risk in childhood brain tumor survivors
  34. Evaluation of Metabolic and Cardiovascular Risk Measured by Laboratory Biomarkers and Cardiopulmonary Exercise Test in Children and Adolescents Recovered from Brain Tumors: The CARMEP Study
  35. Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study
  36. Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics
  37. Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome
  38. Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma
  39. Tyrosine Kinase Inhibitors and Thyroid Toxicity
  40. Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients
  41. Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee
  42. Retrospective Study on Staphylococcus aureus Resistance Profile and Antibiotic Use in a Pediatric Population
  43. Long term use of eltrombopag in children with chronic immune thrombocytopenia: extended real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology
  44. The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology
  45. Pregnancy-associated Cancer and Chemotherapy during Pregnancy
  46. GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia
  47. Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass
  48. Left Ventricular-Arterial Coupling and Vascular Function in Childhood Cancer Survivors Exposed to Anthracycline Chemotherapy
  49. Bisphosphonates: From Pharmacology to Treatment
  50. Successful stem cell collection for atypical teratoid rhabdoid tumor in an extremely low‐body weight child: A case report
  51. Atypical Teratoid Rhabdoid Tumor: Proposal of a Diagnostic Pathway Based on Clinical Features and Neuroimaging Findings
  52. Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors
  53. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers
  54. Optic Pathway Gliomas: The Trends of Basic Research to Reduce the Impact of the Disease on Visual Function
  55. Telomerase and Anticancer Treatment
  56. Pediatric low-grade glioma and neurofibromatosis type 1: A single-institution experience
  57. The Italian Version of the Pediatric Quality of Life Inventory™ (Pedsql™) 3.0 Healthcare Satisfaction Hematology/oncology Module: Reliability and Validity in Radiation Oncology
  58. Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine
  59. Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment
  60. Catheter-related complications in onco-hematologic children: A retrospective clinical study on 227 central venous access devices
  61. BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors
  62. The DNA-topoisomerase Inhibitors in Cancer Therapy
  63. Transplacental Passage and Fetal Effects of Antineoplastic Treatment during Pregnancy
  64. Growth hormone replacement therapy in pediatric brain tumor survivors
  65. Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors
  66. Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study
  67. Oral Microbiota during Childhood and Its Role in Chemotherapy-Induced Oral Mucositis in Children with Cancer
  68. Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study
  69. Nutritional status in the pediatric oncology patients
  70. Hematological disorders in children with Down syndrome
  71. Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed)
  72. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity
  73. Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma
  74. Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients
  75. Role of Partial Splenectomy in Hematologic Childhood Disorders
  76. Editorial: Adverse and Toxic Effects of Childhood Cancer Treatments
  77. Prognostic impact of sarcopenia in children with cancer: a focus on the psoas muscle area (PMA) imaging in the clinical practice
  78. Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol
  79. Acute Tumor Lysis Syndrome: A Metabolic Emergency in Cancer Patients
  80. The Role of Bisphosphonates in Childhood Diseases
  81. Psychological Impact of COVID-19 on Parents of Pediatric Cancer Patients
  82. Transdermal buprenorphine for pain management in children
  83. 131-I-metaiodobenzylguanidine and chemotherapy for advanced neuroblastoma
  84. ALK ‐rearranged histiocytosis: Report of two cases with involvement of the central nervous system
  85. Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
  86. Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy
  87. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment
  88. hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF
  89. Pediatric ERCP with a single-use duodenoscope in an immunocompromised child
  90. Management of Oral Mucositis in Children With Malignant Solid Tumors
  91. The Multidimensional Assessment for Pediatric Patients in Radiotherapy (M.A.P.-RT) Tool for Customized Treatment Preparation: RADAR Project
  92. The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models
  93. Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era
  94. Editorial for the series on pain therapy
  95. Intranasal drugs for analgesia and sedation in children admitted to pediatric emergency department: a narrative review
  96. Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications
  97. Opioid transdermal delivery system: a useful method for pain management in children
  98. Managing children with brain tumors during the COVID-19 era: Don’t stop the care!
  99. Management of Children with Optic Gliomas and Neurofibromatosis Type 1
  100. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
  101. Psychological impact of COVID-19 on parents of pediatric cancer patients
  102. Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells
  103. Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-up
  104. Treatment and Long-Term Sequelae in Childhood Brain Tumors
  105. Cisplatin-induced nephrotoxicity in children: what is the best protective strategy?
  106. Childhood Medulloblastoma: Old Challenges, New Perspectives
  107. Bone and Soft Tissue Sarcoma
  108. Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
  109. CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models
  110. Diagnosis of COVID‐19 infection in children: Less nasopharyngeal swabs, more saliva
  111. Temozolomide and oral etoposide in children with recurrent malignant brain tumors
  112. Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
  113. Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer
  114. Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
  115. Facing the COVID-19 outbreak in children with cancer
  116. Additional hypotheses about why COVID‐19 is milder in children than adults
  117. Covid-19 and children with cancer: are they at increased risk of infection?
  118. Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management
  119. Efficacy of Temozolomide in Children with Solid Tumors
  120. Gynecological cancer among adolescents and young adults (AYA)
  121. Use of Eltrombopag in Children With Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
  122. Cisplatin Toxicity in Children with Malignancy
  123. Neonatal pharmacology and clinical implications
  124. Adult medulloblastoma: an overview on current and future strategies of treatment
  125. Prognostic role of pleural effusion or ascites in localized rhabdomyosarcoma
  126. Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors
  127. Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies
  128. Relapsed papillary urothelial neoplasm of low malignant potential (PUNLMP) of the young age: a case report and a review of the literature
  129. The impact of lacto-ovo-/lacto-vegetarian and vegan diets during pregnancy on the birth anthropometric parameters of the newborn
  130. Undifferentiated Embryonal Sarcoma of the Liver (UESL) in Adolescents
  131. Sleep and arousal disturbances in enuretic children: are there any effects on the height?
  132. Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction
  133. Social programs on providing care for children who underwent parental death and parental separation
  134. Correction to: Multimodal treatment of pediatric patients with Askin’s tumors: our experience
  135. Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee
  136. Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-up
  137. Multimodal treatment of pediatric patients with Askin’s tumors: our experience
  138. The impact of motivational therapy in the management of enuretic children
  139. Focus on children murdered by parents in Italy: A sad reality
  140. Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma
  141. Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment
  142. Central nervous system involvement in children and adolescents with rhabdomyosarcoma. A report from the AIEOP Soft Tissue Sarcoma Committee
  143. Oral Desmopressin Lyophilisate Formulation (MELT): Efficacy and Safety in Children and Adults
  144. Il bambino violato: aspetti moderni del maltrattamento che il pediatra deve conoscere
  145. Can partial splenectomy preserve humoral immunity in pediatric patients? Risks and benefits of partial splenectomy
  146. Safety of the Recent Oral Lyophilisate Formulation (MELT) in Pediatric Patients-A Review
  147. Renal toxicity in children receiving chemotherapy
  148. Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report
  149. Salvage rates and prognostic factors after relapse in children and adolescents with malignant peripheral nerve sheath tumors
  150. Hypersensitivity to Carboplatin in Children with Malignancy
  151. Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
  152. BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities
  153. Erratum to: NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study
  154. Hemophagocytic lymphohistiocytosis and visceral leishmaniasis in children: case report and systematic review of literature
  155. Management of Hyperleukocytosis
  156. Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial
  157. NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study
  158. Audiological Monitoring in Children Treated with Platinum Chemotherapy
  159. The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
  160. Co-inheritance of G6PD and PK deficiencies in a neonate carrying aNovel UGT1A1genotype associated to Crigler-Najjar type II syndrome
  161. Neuropsychological Deterioration Predicts Tumor Progression in a Young Boy With Bithalamic Glioma
  162. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment
  163. Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?
  164. Paroxysmal Nocturnal Hemoglobinuria Clones in Children with Acquired Aplastic Anemia: A Multicentre Study
  165. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial
  166. Critical Pulmonary Infection Due to Nontuberculous Mycobacterium in Pediatric Leukemia
  167. Platinum compounds in children with cancer
  168. Platinum compounds and sodium metabolism in children with diencephalic glioma
  169. Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer
  170. Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors
  171. Safe lumbar puncture under analgo-sedation in children with acute lymphoblastic leukemia
  172. Salivary alpha-amylase: a new non-invasive biomarker for assessment of pain perception in epileptic children
  173. Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain
  174. Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia
  175. Azole interactions with multidrug therapy in pediatric oncology
  176. Cardiac Metastases of Ewing Sarcoma Detected by 18F-FDG PET/CT
  177. Vaccination in children with cancer: a debate
  178. Chronic Idiopathic Thrombocytopenic Purpura in children: predictive factors and outcome
  179. Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome
  180. Expression of liquoral neuroprotection markers in children with acute lymphoblastic leukemia
  181. How to manage vaccinations in children with cancer
  182. The role of diet on the clinical pharmacology of oral antineoplastic agents
  183. Management of children with Thrombocytopenia-absent radius syndrome: An institutional experience
  184. Gastric Adenocarcinoma Presenting as Thrombotic Microangiopathy in a 14-year-old Girl
  185. Massive venous thrombosis of inferior vena cava as primary manifestation of renal Ewing’s sarcoma
  186. Comparison of propofol versus propofol-ketamine combination in pediatric oncologic procedures performed by non-anesthesiologists
  187. Tension Chylothorax Complicating Acute Malignant Airway Obstruction
  188. Topical Nerve Growth Factor as a Visual Rescue Strategy in Pediatric Optic Gliomas
  189. Pretreatment neuropsychological deficits in children with brain tumors
  190. Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of 131 I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen
  191. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma
  192. Intranasal lidocaine and midazolam for procedural sedation in children
  193. Hepatic Veno-Occlusive Disease
  194. Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors
  195. Propofol/alfentanil and propofol/ketamine procedural sedation in children with acute lymphoblastic leukaemia: safety, efficacy and their correlation with pain neuromediator expression
  196. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn
  197. Groshong catheter-related complications in children with cancer
  198. Familial hypobetalipoproteinemia: early neurological, hematological, and ocular manifestations in two affected twins responding to vitamin supplementation
  199. Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: Is it time to change treatment?
  200. Aplastic anaemia in childhood. Description of two cases and review of the literature
  201. Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome
  202. The Neurofibromatosis type 1:A dominantly inherited tumors-predisposing disorder
  203. Transdermal buprenorphine in children with cancer-related pain
  204. Noninvasive ventilation in large postoperative flail chest
  205. Nocturnal Enuresis in Children: A Review of the Literature
  206. Safety and efficacy of two protocols for sedation in pediatric oncology procedures
  207. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings
  208. Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy
  209. Paediatric Kikuchi–Fujimoto disease: A benign cause of fever and lymphadenopathy
  210. Assessment of chemotherapy-induced anemia in children with cancer
  211. ANTHRACYCLINE CARDIOTOXICITY IN CHILDHOOD
  212. Patient-controlled analgesia with fentanil and midazolam in children with postoperative neurosurgical pain
  213. Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy
  214. Homotoxicological remedies versus desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial
  215. Reply to Dr Christopher S Greeley
  216. MRI findings in Shwachman diamond syndrome
  217. Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain
  218. A newborn with multiple fractures as first presentation of infantile myofibromatosis
  219. Acute aseptic meningitis inducing migraine-like attacks in a 7-year-old child
  220. Rosai-Dorfman Disease
  221. Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma
  222. CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN: Case Reports of Spontaneous Recovery Without Splenectomy
  223. Phase II trial of temozolomide in children with recurrent high-grade glioma
  224. Life-threatening presentation of mediastinal neoplasms: report on 7 consecutive pediatric patients
  225. SECOND CASE OF HEPATOBLASTOMA IN A YOUNG PATIENT WITH SIMPSON-GOLABI-BEHMEL SYNDROME
  226. Critical presentation of pleuropulmonary blastoma
  227. Massive Congenital Intracranial Teratoma Perioperative Coagulation Impairment
  228. Candida parapsilosisBloodstream Infection in Pediatric Oncology Patients: Results of an Epidemiologic Investigation
  229. Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas
  230. A CASE OF ACUTE LYMPHOBLASTIC LEUKEMIA PRESENTING AS SEVER HYPERCALCEMIA
  231. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas
  232. COMMENTS ON: Megadose Methylprednisolone for the Treatment of Patients with Evans Syndrome
  233. MALIGNANT RETROPERITONEAL PARAGANGLIOMACase Report and Review of the Literature
  234. Pulmonary Hemorrhage Complicating a Typical Hemolytic-Uremic Syndrome
  235. Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients
  236. Management of critically ill children with mediastinal neoplasms: A 6-year survey from a single institution
  237. Microangiopathic Hemolytic Anemia Complicating a Postneonatal Pertussis Pneumonia
  238. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia
  239. Cellular and molecular aspects of drugs of the future: oxaliplatin
  240. High Response Rate to Cisplatin/Etoposide Regimen in Childhood Low-Grade Glioma
  241. Interventions for anemia in pediatric cancer patients
  242. Plasma Antidiuretic Hormone Levels in Children with Spina bifida
  243. CARCINOID TUMORS OF THE APPENDIX IN CHILDREN: Two Case Reports and Review of the Literature
  244. Primary Nocturnal Enuresis and Left-handedness
  245. Diamond–Blackfan Anemia and Midline Defects
  246. Two Different Desmopressin (DDAVP) Regimens in Enuretic Monozygotic Twins with Allergic Diathesis
  247. Early Reactive Neutrophil Changes in an Infant With Kawasaki Syndrome
  248. Hypersensitivity Reactions to Drugs